Major Shareholding Notification • Sep 1, 2023
Major Shareholding Notification
Open in ViewerOpens in native device viewer

IBA (Ion Beam Applications), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on August 29th 2023.
In its notification, NS Partners Europe S.A has notified, that following the passive crossing of a threshold, its total holding in IB SA has crossed upwards the 1% threshold.
| A) Voting rights | Previous notification | After the transaction | |||||
|---|---|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | |||||
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities |
Not linked to the securities |
|||
| Paolo FARAONE | 0 | 0.00% | |||||
| Christophe LENTSCHAT | O | 0.00% | |||||
| Grégoire NOTZ | 0 | 0.00% | |||||
| NS Partners Europe S.A. | 405,355 | 1.01% | |||||
| Subtotal | 405,355 | 1.01% | |||||
| TOTAL | 405,355 | 0 | 1.01% | 0.00% |

IBA | Ion Beam Applications SA Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant-wallon VAT : 0428.750.985 | T +32 10 47 58 11 | F +32 10 47 58 10 [email protected] | iba-worldwide.com

1

| B) Equivalent financial instruments | After the transaction | |||||||
|---|---|---|---|---|---|---|---|---|
| Holders of equivalent financial instruments |
Type of financial instrument | Expiration date | Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights | Settlement | ||
| TOTAL | 0 | 0.00% | ||||||
| The totals will be updated once you have clicked on B |
||||||||
| TOTAL (A & B) | # of voting rights | % of voting rights | ||||||
| CALCULATE | 405,355 | 1.01% |
capital of the company.
As a result, the ultimate controlling persons are the board members: Mr. Paolo FARAONE, Mr. Christophe LENTSCHAT, and Mr. Grégoire NOTZ.
NS Partners Europe S.A. acts as AIFM of the fund Lux-Investment Professionals SICAV-FIS S.A. Ultimately holding IBA shares.
NS Partners Europe S.A., in agreement with Lux-Investment Professionals Sicav-FIS S.A. prospectus and the AIFM Voting right policy may exercise the voting rights on a discretionary basis, without specific
instructions from the unit holder of the fund.
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,800 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
Press release | 31/08/ 2023



IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
For further information, please contact:
Valérie Van Impe Paralegal +32479267809 [email protected]
Press release | 31/08/ 2023

IBA | Ion Beam Applications SA Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant-wallon VAT : 0428.750.985 | T +32 10 47 58 11 | F +32 10 47 58 10 [email protected] | iba-worldwide.com

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.